Combination of efalizumab and acitretin in chronic plaque psoriasis

J Eur Acad Dermatol Venereol. 2008 Feb;22(2):247-8. doi: 10.1111/j.1468-3083.2007.02303.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acitretin / adverse effects
  • Acitretin / therapeutic use*
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Chronic Disease
  • Drug Therapy, Combination
  • Female
  • Humans
  • Keratolytic Agents / adverse effects
  • Keratolytic Agents / therapeutic use*
  • Middle Aged
  • Psoriasis / drug therapy*
  • Psoriasis / pathology
  • Skin / pathology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Keratolytic Agents
  • Acitretin
  • efalizumab